ストックスクリーナーアプリを入手
3.05
0.66%
0.02
前日終値:
$3.03
開ける：
$3.04
24時間の取引高:
1.43M
Relative Volume:
0.30
時価総額：
$329.11M
収益：
-
当期純損益:
$-258.08M
株価収益率:
-1.1091
EPS:
-2.75
ネットキャッシュフロー:
$-202.32M
1週間 パフォーマンス:
+6.64%
1か月 パフォーマンス:
+8.54%
6か月 パフォーマンス:
-70.87%
1年 パフォーマンス:
-83.60%
1日の値動き範囲:
$3.035
$3.15
1週間の範囲:
$2.83
$3.22
52週間の値動き範囲:
$2.19
$22.01
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
名前
Rocket Pharmaceuticals Inc
セクター
電話
646-440-9100
住所
350 FIFTH AVENUE, NEW YORK, NY
RCKT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.05 | 326.95M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-30 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-05-28 | ダウングレード | Goldman | Neutral → Sell |
| 2025-05-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-05-28 | ダウングレード | Jefferies | Buy → Hold |
| 2025-05-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | ダウングレード | Needham | Buy → Hold |
| 2025-05-27 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2024-12-30 | 開始されました | Wedbush | Outperform |
| 2024-12-18 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-04-02 | 開始されました | Goldman | Neutral |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 開始されました | Morgan Stanley | Overweight |
| 2022-11-08 | 開始されました | Canaccord Genuity | Buy |
| 2022-11-01 | 開始されました | BTIG Research | Buy |
| 2022-07-08 | 開始されました | Raymond James | Outperform |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2021-02-18 | 開始されました | Needham | Buy |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-12-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 開始されました | JP Morgan | Overweight |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2019-11-06 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-26 | 開始されました | Piper Jaffray | Overweight |
| 2019-04-23 | 開始されました | Robert W. Baird | Outperform |
| 2019-03-15 | 開始されました | BofA/Merrill | Buy |
| 2019-02-05 | 開始されました | Oppenheimer | Outperform |
| 2018-09-13 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-10 | 開始されました | William Blair | Outperform |
すべてを表示
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
How to build a custom watchlist for Rocket Pharmaceuticals Inc. Equity WarrantTrade Exit Report & Weekly Stock Breakout Alerts - Newser
Using economic indicators to assess Rocket Pharmaceuticals Inc. Equity Warrant potentialWeekly Trend Summary & Community Driven Trade Alerts - Newser
Can a trend reversal in Rocket Pharmaceuticals Inc. lead to recoveryJuly 2025 Volume & Daily Growth Stock Tips - Newser
Risk adjusted return profile for Rocket Pharmaceuticals Inc. Equity Warrant analyzedJuly 2025 Price Swings & Weekly Breakout Stock Alerts - Newser
Rocket Pharmaceuticals Inc. Equity Warrant’s volatility index tracking explainedBreakout Watch & Real-Time Buy Signal Alerts - Newser
Forecasting Rocket Pharmaceuticals Inc. price range with options dataQuarterly Growth Report & Daily Entry Point Alerts - Newser
Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha
Rocket Pharmaceuticals Inc. stock trend outlook and recovery pathBull Run & Smart Allocation Stock Tips - Newser
Published on: 2025-08-14 16:12:45 - newsyoung.net
Trendlines Converge — Decision Point for Rocket Pharmaceuticals Inc. Equity WarrantMarket Sentiment Review & Risk Controlled Daily Plans - 선데이타임즈
XTX Topco Ltd Cuts Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Chardan Capital Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price - Defense World
Rocket Pharmaceuticals Maintains Hold Rating Amid Clinical and Financial Uncertainties - AInvest
Rocket Pharmaceuticals Faces Investor Lawsuit Over Fatal Gene Therapy Trial – How to Join the Case - TradingView
Did You Lose Money on Rocket Pharmaceuticals, Inc. (RCKT)? Levi & Korsinsky Urges Investors to Act Before August 11, 2025 - Barchart.com
Deadline coming up on Aug. 11th in Lawsuit for Investors who lost - openPR.com
DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - Business Wire
Rocket Pharmaceuticals Class Action Filed, Deadline August 11, 2025. - AInvest
DEADLINE ALERT for RCKT, TEM, and DDD: The Law Offices of - GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - Barchart.com
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025RCKT - PR Newswire
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit - MarketScreener
Rocket Pharmaceuticals, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before August 11, 2025 to Discuss Your RightsRCKT - PR Newswire
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rocket Pharmaceuticals sued for securities fraud, lead plaintiff deadline Aug. 11. - AInvest
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals - Bluefield Daily Telegraph
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
Has Rocket Pharmaceuticals Inc. Equity Warrant found a price floorFree Scalable Portfolio Growth Suggestions - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant forming a reversal patternReversal Signal Prediction Based on Volume - Newser
What high frequency data says about Rocket Pharmaceuticals Inc.Weekly Gain Forecast with Momentum Indicators - Newser
Will breakout in Rocket Pharmaceuticals Inc. lead to full recoveryProfit Target Planning with Exit Confidence - Newser
RCKT DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class ActionRCKT - ACCESS Newswire
Rocket Pharmaceuticals Hit with Class Action Lawsuit Over Securities Fraud - AInvest
Rocket Pharmaceuticals and the Rocketing Risks in Biotech Innovation - AInvest
Faruqi & Faruqi Investigates Rocket Pharmaceuticals Securities Litigation - AInvest
Combining machine learning predictions for Rocket Pharmaceuticals Inc. Equity Warrant2-Day Signal Watch with Forecast Outcome - Newser
RCKT IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 11 Deadline in Securities Class ActionRCKT - ACCESS Newswire
Should you wait for a breakout in Rocket Pharmaceuticals Inc.Profitable Trading Blueprint with Entry Zones - Newser
Custom watchlist performance reports with Rocket Pharmaceuticals Inc.Free Exit Ready Momentum Stock Watchlist - Newser
Rocket Pharmaceuticals Inc. Equity Warrant stock momentum explainedBreakout Watcher with Entry and Exit Alerts - Newser
Volume spikes in Rocket Pharmaceuticals Inc. stock – what they meanSafe Entry Screening with Data Backed Analysis - Newser
Class Action Lawsuit Filed: Rocket Pharmaceuticals, Inc. (RCKT)Join by August 11, 2025Contact Levi & Korsinsky - Stockhouse
Class Action Filed Against Rocket Pharmaceuticals, Inc. - GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for Investors – Contact Levi & Korsinsky - Morningstar
Rocket Pharmaceuticals and the Biotech Litigation Landscape: Navigating Risks in a High-Stakes Sector - AInvest
Rocket Pharmaceuticals Lawsuit Deadline Approaches: Investors Advised to Contact Law Offices of Frank R. Cruz - AInvest
August 11, 2025 Deadline: Join Class Action Lawsuit Against Rocket Pharmaceuticals, Inc. (RCKT)Contact Levi & Korsinsky - Barchart.com
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class - GlobeNewswire
Rocket Pharmaceuticals stock price target raised to $3.00 from $2.50 at Jefferies - Investing.com Canada
Rocket Pharmaceuticals Inc (RCKT) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):